Records containing: Uveal Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-10A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients With Hepatic-Dominant Ocular Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-15Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients
-
CLINICAL_TRIALS study record update · 2026-04-03First in Human Phase I Study of 225Actinium-MTI-201 (225Ac-MTI-201) in Metastatic Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-02A Proof of Concept Study of TBio-4101 (an Autologous Selected and Expanded Tumor Infiltrating Lymphocyte [TIL] Therapy) Using Short-Term Cultured, Selected Autologous TIL Following a Lymphodepleting Chemotherapy Regimen and Followed by IL-2 for Patients With Relapsed or Refractory Melanoma (Phase 1)
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase II Trial of Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-30Neoadjuvant Ipilimumab and Nivolumab for Patients With High-risk Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2026-03-30First-in-Human Dose Study of IOA-244 in Patients With Advanced or Metastatic Cancers
-
CLINICAL_TRIALS study record update · 2026-03-19Promoting Adjustment in Uveal Melanoma Survivorship: A Randomized Trial Targeting Illness Perceptions
-
CLINICAL_TRIALS study record update · 2026-03-19Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2026-03-17Phase I Dose Escalation Study of Systemically Administered IL13Ra2 Chimeric Antigen Receptor (CAR) T Cells After a Nonmyeloablative Conditioning Regimen in Patients With Metastatic Melanoma and Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-16(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
-
CLINICAL_TRIALS study record update · 2026-03-11Evaluating Immune Response to Percutaneous Hepatic Perfusion With Melphalan for the Treatment of Ocular Melanoma Metastatic to the Liver
-
CLINICAL_TRIALS study record update · 2026-03-09Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
-
CLINICAL_TRIALS study record update · 2026-03-04Adjuvant Tebentafusp (IMCgp100) Versus Observation in HLA-A*02:01 Positive Patients Following Definitive Treatment of High-risk Uveal Melanoma: an EORTC Randomized Phase III Study (ATOM Trial)
-
CLINICAL_TRIALS study record update · 2026-03-02A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
-
CLINICAL_TRIALS study record update · 2026-02-27Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)
-
CLINICAL_TRIALS study record update · 2026-02-19Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
-
CLINICAL_TRIALS study record update · 2026-02-18A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in Subjects With Primary Non-metastatic Uveal Melanoma (OptimUM-10)
-
CLINICAL_TRIALS study record update · 2026-02-17ClinicalTrials.gov study NCT02517736
-
CLINICAL_TRIALS study record update · 2026-02-04A Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144 or LN-145) for Patients With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
-
CLINICAL_TRIALS study record update · 2026-01-30Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-01-28A NON-COMMERCIAL, MULTICENTER, RANDOMIZED, TWO-ARMED, OPEN-LABEL PHASE III STUDY TO EVALUATE THE ADJUVANT VACCINATION WITH TUMOR RNA-LOADED AUTOLOGOUS DENDRITIC CELLS VERSUS OBSERVATION OF PATIENTS WITH RESECTED MONOSOMY 3 UVEAL MELANOMA
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase II, Multi-centre, Open Label, Randomised Study to Evaluate the Anti-tumour Activity of Roginolisib in Patients With Advanced/Metastatic Ocular/Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2026-01-07A Phase 1 Study of [225Ac]-FPI-1434 Injection in Patients With Locally Advanced or Metastatic Solid Tumours
-
CLINICAL_TRIALS study record update · 2025-11-17Screening Study to Determine HLA Type, HLA Loss of Heterozygosity Status and Tumor Antigen Expression in Participants With Locally Advanced (Unresectable) or Metastatic Solid Tumors